Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]

Prostate cancer patients receiving androgen-deprivation therapies shown to be...

Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona...

Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19 ( Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland )

COVID-19: The situation in Peru and managing radiotherapy patients

Dr. Gustavo Sarria – Presidente en Sociedad de Radioterapia del Peru, Lima, Peru

COVID-19: The situation in Peru and managing radiotherapy patients ( Dr. Gustavo Sarria – Presidente en Sociedad de Radioterapia del Peru, Lima, Peru )

Novel treatment strategies for prostate cancer: Senescence, senolytics and...

Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland

Novel treatment strategies for prostate cancer: Senescence, senolytics and myeloid derived suppressor cells ( Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland )

Shorter hormone therapy for prostate cancer

Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City...

Shorter hormone therapy for prostate cancer ( Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City, Canada )

Micro-ultrasound for detection of clinically significant prostate cancer

Dr Davide Maffei - Humanitas University, Milan, Italy

Micro-ultrasound for detection of clinically significant prostate cancer ( Dr Davide Maffei - Humanitas University, Milan, Italy )

Revolutionising imaging with PSMA PET in prostate cancer

Dr Bernard Henk-Erik Jansen - VU University Medical Center, Amsterdam, The...

Revolutionising imaging with PSMA PET in prostate cancer ( Dr Bernard Henk-Erik Jansen - VU University Medical Center, Amsterdam, The Netherlands )

Follow up from MRI imaging for low-grade prostate cancer

Dr Henk B. Luiting - University of Groningen, Groningen, The Netherlands

Follow up from MRI imaging for low-grade prostate cancer ( Dr Henk B. Luiting - University of Groningen, Groningen, The Netherlands )

Over-diagnosis of low-grade prostate cancer, good or bad?

Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium

Over-diagnosis of low-grade prostate cancer, good or bad? ( Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium )

Updates in imaging for oligometastatic disease in urological cancers

Dr Tobias Maurer - University Hospital Hamburg-Eppendorf, Hamburg, Germany

Updates in imaging for oligometastatic disease in urological cancers ( Dr Tobias Maurer - University Hospital Hamburg-Eppendorf, Hamburg, Germany )

PRIAS: Active surveillance for men with low risk prostate cancer

Prof Monique J. Roobol - Erasmus University Medical Center, Rotterdam, The...

PRIAS: Active surveillance for men with low risk prostate cancer ( Prof Monique J. Roobol - Erasmus University Medical Center, Rotterdam, The Netherlands )

EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or...

Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA

EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma ( Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )

KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC

Dr Julie Graff - Oregon Health & Science University, Portland, USA

KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC ( Dr Julie Graff - Oregon Health & Science University, Portland, USA )

More from ecancer